These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6863572)

  • 1. Plasma spermidine concentrations as early indication of response to therapy in human myeloma.
    Van Dobbenburgh OA; Houwen B; Jurjens H; Marrink J; Halie MR; Nieweg HO
    J Clin Pathol; 1983 Jul; 36(7):804-7. PubMed ID: 6863572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vindesine therapy in melphalan-resistant multiple myeloma.
    Houwen B; Ockhuizen T; Marrink J; Nieweg HO
    Eur J Cancer (1965); 1981 Feb; 17(2):227-32. PubMed ID: 7262159
    [No Abstract]   [Full Text] [Related]  

  • 3. Prednisone pulse therapy for refractory myeloma.
    Alexanian R; Yap BS; Bodey GP
    Blood; 1983 Sep; 62(3):572-7. PubMed ID: 6882916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress report on vindesine treatment of melphalan-resistant multiple myeloma.
    van Dobbenburgh OA; Houwen B; Halie MR; Marrink J; Ockhuizen T; Nieweg HO
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):861-2. PubMed ID: 6683653
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclophosphamide, doxorubicin, prednisone and vindesine combination chemotherapy in melphalan-resistant multiple myeloma.
    Van Dobbenburgh OA; Houwen B; Piersma H; Marrink J; Ockhuizen T; Halie MR; Nieweg HO
    Neth J Med; 1984; 27(2):25-30. PubMed ID: 6709108
    [No Abstract]   [Full Text] [Related]  

  • 6. Spermidine level as a parameter in the treatment of patients with malignant melanoma.
    Smit JM; Jurjens H; Bouman J; Bijzet J; Sleijfer DT; Woldring MG; Mulder NH
    Eur J Nucl Med; 1985; 10(5-6):276-7. PubMed ID: 2580707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative usefulness of measuring polyamines in serum, plasma, and urine as biochemical markers of cancer.
    Russell DH; Russell SD
    Clin Chem; 1975 Jun; 21(7):860-3. PubMed ID: 48436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of the blast crisis in chronic myeloid leukemia. Results of a phase II study with vindesine].
    Hellriegel KP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):699-706. PubMed ID: 6172337
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple myeloma with high tumour mass. Treatment with high-dose methylprednisolone, cyclophosphamide and vindesine.
    van Dobbenburgh OA; Halie MR; Piersma H; Marrink J; Ockhuizen T; Nieweg HO
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):437-9. PubMed ID: 6538503
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phase II study of the treatment of CML blast crisis with vindesine and prednisone].
    Jehn U; Mezger J
    Onkologie; 1984 Dec; 7(6):342-5. PubMed ID: 6396561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status and future prospects of treatment for multiple myeloma.
    Durie BG; Salmon SE
    Clin Haematol; 1982 Feb; 11(1):181-210. PubMed ID: 6176381
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of chronic myeloid leukemia blast crisis with vindesine and prednisone.
    Jehn U; Mezger J
    Cancer Treat Rep; 1985 Apr; 69(4):445-8. PubMed ID: 3857971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of vindesine administration by bolus injection and by 24-hour infusion.
    Gilby ED
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():47-51. PubMed ID: 7438121
    [No Abstract]   [Full Text] [Related]  

  • 14. Initial clinical studies of vindesine.
    Valdivieso M; Richman S; Burgess AM; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):873-5. PubMed ID: 6268296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
    Raich PC; Walker BK; Rogers JS; Subramanian VP; Fontana JA; Knost JA; Denning B
    Cancer Treat Rep; 1983 May; 67(5):485-7. PubMed ID: 6573959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vindesine trials at Memorial Sloan-Kettering Cancer Center.
    Young CW
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():53-7. PubMed ID: 7438122
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vindesine, carmustine, doxorubicin, and prednisone (EBAP) in recurrent lymphomas: a Southwest Oncology Group study.
    Weick JK; Jones SE; Grozea PN; Fabian CJ; Dixon DO
    Cancer Treat Rep; 1984; 68(7-8):963-7. PubMed ID: 6744347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.
    Luedke SL; Luedke DW; Petruska P; Broun GO; Reed G; Leavitt J
    Cancer Treat Rep; 1982 Jun; 66(6):1409-11. PubMed ID: 7083243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I and II studies of vindesine.
    Valdivieso M
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():31-7. PubMed ID: 7438119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.